Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia
- PMID: 6948765
- DOI: 10.1007/BF00294925
Correlations between the clinical course, characteristics of blast cells, and karyotype patterns in chronic myeloid leukemia
Abstract
Results of chromosome studies of blood and bone marrow cells from 101 patients with Ph1 positive chronic myeloid leukemia (CML) confirm the assumptions that clinical and morphologic manifestations of the disease correlate with karyotype peculiarities of leukemia cells. Several variants of the clinical course of CML may be distinguished. One is the variant with a short chronic phase and a comparatively long terminal phase. In blastic crisis the blast cells are peroxidase negative and do not possess cytoplasmic inclusions. Acute transformation occurs without any additional chromosome damage. The second, more common form is less severe because of longer chronic phase but it has a short and grave acute stage. The blast cells present definite signs of myeloid differentiation, they have basophilic or neutrophilic cytoplasmic granules and are peroxidase positive. Marker i(17q) often combined with trisomy 8 is a characteristic chromosome abnormality in the terminal stage of this variant. The third type has an extremely long chronic phase but ends in a rapidly progressing severe and resistant to therapy "lymphoid" blastic crisis. Blast cells have typical "lymphoid" morphology, they are peroxidase negative and contain granular PAS positive substance. Various additional chromosome changes appear in the terminal stage. Future studies of a larger series of patients may possibly reveal more CML variants.
Similar articles
-
Variant Ph1 translocations in CML and their incidence, including two cases with sequential lymphoid and myeloid crises.Cancer Genet Cytogenet. 1982 Mar;5(3):187-201. doi: 10.1016/0165-4608(82)90025-5. Cancer Genet Cytogenet. 1982. PMID: 6950809
-
9;22;15 complex translocation in Ph1 chromosome positive CML revealed by Giemsa-11 procedure in apparent lymphoid cells of blastic crisis.Cancer Genet Cytogenet. 1981 Dec;4(4):283-92. doi: 10.1016/0165-4608(81)90024-8. Cancer Genet Cytogenet. 1981. PMID: 6949632
-
Discordant patterns of chromosome changes and myeloblast proliferation during the terminal phase of chronic myeloid leukemia.Blood. 1976 Mar;47(3):347-53. Blood. 1976. PMID: 1062222
-
Relapse and cytogenetic evolution in myeloid neoplasms.Panminerva Med. 2017 Dec;59(4):308-319. doi: 10.23736/S0031-0808.17.03380-8. Panminerva Med. 2017. PMID: 29144072 Review.
-
[Cytogenetic findings in chronic myelogenous leukemia].Folia Haematol Int Mag Klin Morphol Blutforsch. 1985;112(4):495-514. Folia Haematol Int Mag Klin Morphol Blutforsch. 1985. PMID: 2414179 Review. German.
Cited by
-
Prognostic significance of isochromosome 17q in hematologic malignancies.Oncotarget. 2021 Mar 30;12(7):708-718. doi: 10.18632/oncotarget.27914. eCollection 2021 Mar 30. Oncotarget. 2021. PMID: 33868591 Free PMC article.
-
Karyotypic progression in human tumors.Cancer Metastasis Rev. 1983;2(3):257-93. doi: 10.1007/BF00048481. Cancer Metastasis Rev. 1983. PMID: 6231097 Review.
-
The spectrum of molecular alterations in the evolution of chronic myelocytic leukemia.J Clin Invest. 1991 Jun;87(6):2042-7. doi: 10.1172/JCI115234. J Clin Invest. 1991. PMID: 2040694 Free PMC article.
-
Acute lymphoblastic leukemia with t(1;9;22)(q32;q34;q11).Int J Hematol. 2002 May;75(4):443-5. doi: 10.1007/BF02982140. Int J Hematol. 2002. PMID: 12041680 No abstract available.
-
del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.Cancer Genet Cytogenet. 2009 Jul;192(1):18-23. doi: 10.1016/j.cancergencyto.2009.02.017. Cancer Genet Cytogenet. 2009. PMID: 19480932 Free PMC article.
References
MeSH terms
LinkOut - more resources
Research Materials